Schedule 13D ownership disclosure

TEMPEST THERAPEUTICS INC

Security class unavailable · CUSIP: 87978U108

Event date: 2024-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-199144
Form type
SC 13D/A
Filer
Tempest Therapeutics, Inc.
CIK
CIK 1544227
Filed
Aug 12, 2024
Reporting period
Aug 08, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub